comparemela.com

Latest Breaking News On - Xlife sciences - Page 11 : comparemela.com

FUSE-AI supports German pharmacies in digitization

04.07.2022 - Xlife Sciences AG / Key word(s): Miscellaneous FUSE-AI supports German pharmacies in digitization 04.07.2022 / 07:01 Xlife Sciences’ (SIX: XLS) project company FUSE-AI has been appointed as strategic partner in the field of digitization by the . Seite 1

Matthias steffenKapitalmarkt conferenceYear resultsXlife sciences

In brief: the IPO market and regulatory framework in Switzerland

A look at some of the key market and regulatory issues surrounding initial public offerings in Switzerland, including market dynamics and prospectus requirements, among other things.

Switzerland generalSwiss exchange ltdSulzer groupEnforcement departmentAdministrative courtSwiss financial market supervisory authorityAcquisition companyGroup ltdExchange regulationM company united statesCosmo pharmaceuticalsFinancial services ordinance finFinancial services act finNewron pharmaceuticalsCredit suisseFinancial services

Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project

16.05.2022 Project company Xsight Optics successfully participates in start-up competition – prize money finances relevant R&D project | Xlife Sciences AG | News | Nachricht | Mitteilung

Jan sperrhakeOliverr baumannXsight optisMaria nisserTechnology associationInstitute for applied building research weimarThuringia ministry of economicsXlife sciencesThuringia researchXsight opticsThuringia ministryIntelligent systems departmentApplied building researchThuringian startupApplied building research weimarXsight optic

Project company Xsight Optics successfully participates in start-up competition prize money finances relevant R&D project

Xlife Sciences AG / Key word(s): Miscellaneous Project company Xsight Optics successfully participates in start-up competition prize.

Jan sperrhakeOliverr baumannXsight optisMaria nisserTechnology associationInstitute for applied building research weimarThuringia ministry of economicsXlife sciencesThuringia researchXsight opticsThuringia ministryIntelligent systems departmentApplied building researchThuringian startupApplied building research weimarXsight optic

Xlife Sciences: First Valuation Report confirms substancial potential of the project portfolio and assumes CHF 574 million in the most conservative scenario Seite 1

09.05.2022 - Xlife Sciences AG / Key word(s): Miscellaneous Xlife Sciences: First Valuation Report confirms substancial potential of the project portfolio and assumes CHF 574 million in the most conservative scenario 09-May-2022 / 07:00 CET/CEST Release of an . Seite 1

Quadira biosciencesOliverr baumannXlife sciencesEvaluation reportVeraxa biotechCylad experts

vimarsana © 2020. All Rights Reserved.